Exelixis | Dochód Netto



Net Income Zmiana Data
Acadia Pharmaceuticals USD 26.67M 7.68M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Amgen USD 1.73B 1.1B 2025-03
AstraZeneca USD 2.45B 466M 2025-06
Bayer EUR 1.3B 1.63B 2025-03
BioMarin Pharmaceutical USD 240.53M 54.85M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Cytokinetics USD -134370000 27.01M 2025-06
Eisai JPY 14.47B 13.52B 2025-06
Eli Lilly USD 5.66B 2.9B 2025-06
Exelixis USD 230.42M 70.8M 2025-07
Genmab DKK 195M 3.65B 2025-03
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 405M 246.8M 2025-06
Ionis Pharmaceuticals USD 123.55M 270.49M 2025-06
MacroGenics USD -15421000 71.73M 2024-12
Merck USD 4.43B 652M 2025-06
Moderna USD -825000000 146M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Novartis USD 4.02B 418M 2025-06
Pfizer USD 2.91B 58M 2025-06
Sanofi EUR 499M 2.32B 2024-12
Takeda JPY 124.24B 227.4B 2025-06
Ultragenyx Pharmaceutical USD -114951000 36.13M 2025-06
Xencor USD -48418000 5.06M 2025-03


Exelixis Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.